BRONCO BILLY Co., LTD. (3091.T)
JPY 3745.0
(-0.13%)
JPY 3745.0
(-0.13%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 2.54 Billion | 1.62 Billion | 2.42 Billion | -57.91 Million | 2.42 Billion | 2.79 Billion |
| Net Income | 1 Billion | 1.03 Billion | 1.42 Billion | -413.66 Million | 2.32 Billion | 2.57 Billion |
| Depreciation & Amortization | 874.93 Million | 825.12 Million | 783.45 Million | 820.39 Million | 912.23 Million | 922.42 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 210.39 Million | 176.23 Million | -63.67 Million | -217.77 Million | -99.6 Million | -74.55 Million |
| Other non-cash items | 457.24 Million | -414.18 Million | 276.67 Million | -246.87 Million | -718.33 Million | -633.9 Million |
| Investing Cash Flow | -1.08 Billion | -1.44 Billion | -1.81 Billion | -351.05 Million | -1.83 Billion | -1.76 Billion |
| Investments in PPE | -1.07 Billion | -1.05 Billion | -1.82 Billion | -355.98 Million | -785.51 Million | -1.66 Billion |
| Acquisitions | 185 Thousand | -121.16 Million | -125.95 Million | 2.55 Million | 274 Thousand | - |
| Investment purchases | -17.99 Million | -3.67 Million | -3.69 Million | -15.73 Million | -1.03 Billion | -39.73 Million |
| Sales/Maturities of investments | 24.67 Million | 15.8 Million | 24.61 Million | 21.42 Million | -274 Thousand | - |
| Other Investing Activities | -22.56 Million | -278.5 Million | 107.73 Million | -3.31 Million | -11.88 Million | -54.67 Million |
| Financing Cash Flow | -626.53 Million | -6.11 Billion | 520.23 Million | 4.75 Billion | -371.04 Million | -381.22 Million |
| Debt repayment | -386.46 Million | -6.03 Billion | -199.99 Million | -4.93 Billion | -8.61 Million | -19.11 Million |
| Dividends payments | -239.98 Million | -269.99 Million | -241.42 Million | -181.48 Million | -362.27 Million | -361.71 Million |
| Common Stock Repurchased | -80 Thousand | -524.23 Million | - | -192 Thousand | -163 Thousand | -392 Thousand |
| Common Stock Issuance | - | - | - | -4.93 Billion | 8.61 Million | - |
| Other Financing Activities | -39 Million | 709.45 Million | 961.64 Million | 14.81 Billion | -8.6 Million | -19.11 Million |
| Accounts receivables | -85.26 Million | -14.81 Million | -245.76 Million | -136.19 Million | -87.82 Million | -37.18 Million |
| Accounts payables | 86.24 Million | 194.34 Million | 125.51 Million | -131.3 Million | -62.64 Million | 18.09 Million |
| Inventory | -116.64 Million | -244.07 Million | -16.1 Million | 301.26 Million | -52.22 Million | -192.33 Million |
| Other working capital | 326.06 Million | 240.78 Million | 72.68 Million | -251.54 Million | 103.09 Million | 117.78 Million |
| Cash at beginning of period | 5.65 Billion | 11.59 Billion | 10.47 Billion | 6.12 Billion | 5.9 Billion | 5.25 Billion |
| Cash at end of period | 6.62 Billion | 5.65 Billion | 11.59 Billion | 10.47 Billion | 6.12 Billion | 5.9 Billion |
| Capital Expenditure | -1.07 Billion | -1.05 Billion | -1.82 Billion | -355.98 Million | -785.51 Million | -1.66 Billion |
| Effect of forex changes on cash | 1.16 Billion | - | - | -1000.00 | - | -1000.00 |
| Net cash flow / Change in cash | 966.07 Million | -5.93 Billion | 1.12 Billion | 4.34 Billion | 211.89 Million | 649.71 Million |
| Free Cash Flow | 1.47 Billion | 567.92 Million | 600.5 Million | -413.89 Million | 1.63 Billion | 1.12 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 296 Million | 527 Million | 266 Million | 1 Billion | 403 Million | 146 Million |
| Depreciation & Amortization | - | - | 227.58 Million | 874.93 Million | 223.65 Million | 217.33 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | 210.39 Million | - | - |
| Other non-cash items | -296 Million | -527 Million | -266 Million | 457.24 Million | -403 Million | -146 Million |
| Investing Cash Flow | - | - | - | -1.08 Billion | - | - |
| Investments in PPE | - | - | - | -1.07 Billion | - | - |
| Acquisitions | - | - | - | 185 Thousand | - | - |
| Investment purchases | - | - | - | -17.99 Million | - | - |
| Sales/Maturities of investments | - | - | - | 24.67 Million | - | - |
| Other Investing Activities | - | - | - | -22.56 Million | - | - |
| Financing Cash Flow | - | - | - | -626.53 Million | - | - |
| Debt repayment | - | - | - | -386.46 Million | - | - |
| Dividends payments | - | - | - | -239.98 Million | - | - |
| Common Stock Repurchased | - | - | - | -80 Thousand | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | -39 Million | - | - |
| Accounts receivables | - | - | - | -85.26 Million | - | - |
| Accounts payables | - | - | - | 86.24 Million | - | - |
| Inventory | - | - | - | -116.64 Million | - | - |
| Other working capital | - | - | - | 326.06 Million | - | - |
| Cash at beginning of period | - | - | 7.58 Billion | 5.65 Billion | 6.09 Billion | 6.86 Billion |
| Cash at end of period | - | - | 7.64 Billion | 6.62 Billion | 7.58 Billion | 6.09 Billion |
| Capital Expenditure | - | - | - | -1.07 Billion | - | - |
| Effect of forex changes on cash | - | - | - | 1.16 Billion | - | - |
| Net cash flow / Change in cash | - | - | 61.08 Million | 966.07 Million | 1.49 Billion | -769.69 Million |
| Free Cash Flow | - | - | 455.16 Million | 1.47 Billion | 447.3 Million | 434.67 Million |
0LIU
002713
LPE
002396
LRKKF
BPLPHARMA